Product Information

BRIMONIDINE 0.2% EYE DROP is a generic product labeled by Somerset Therapeutics, LLC, priced at $0.5857 per ML under NDC 70069023201. Its NADAC has been published 356 times since Oct 30, 2019.

FDA first approved this application on Mar 11, 2019. Its Orange Book therapeutic-equivalence code is AT.

BRIMONIDINE 0.2% EYE DROP

BRIMONIDINE TARTRATE
$0.5857per ML

Strength

2 mg/mL

NDC

70069023201

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BRIMONIDINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA208992

FDA Approved

3/11/2019

TE Code

AT

On Market Since

3/11/2019

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price Statistics

The NADAC for BRIMONIDINE 0.2% EYE DROP has been published 356 times since Oct 30, 2019, and over the history we have for it it has declined 30.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5857 per ML
All-time high$0.9515 (Jun 10, 2020)
All-time low$0.4128 (Nov 20, 2024)
52-week high$0.5910
52-week low$0.5553
Median price$0.6146
Average price$0.6545
Largest weekly change+34.4% (Jun 23, 2021)
Weeks tracked356
Tracking sinceOct 30, 2019

Price History

1W

+1.9%

1M

+1.9%

3M

+5.1%

6M

+1.3%

1Y

+4.2%

3Y

-1.7%

5Y

-11.5%

All

-30.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 13%

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of BRIMONIDINE 0.2% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BRIMONIDINE 0.2% EYE DROP, manufactured by Somerset Therapeutics, LLC, is $0.5857 per ML (NDC 70069023201), effective Aug 19, 2026.

How has the price of BRIMONIDINE 0.2% EYE DROP changed over time?

Over the history we have for it, the NADAC for BRIMONIDINE 0.2% EYE DROP has declined 30.5%. It has been tracked across 356 weekly CMS publications since Oct 30, 2019.

What are the highest and lowest recorded NADAC prices for BRIMONIDINE 0.2% EYE DROP?

Since Oct 30, 2019, the NADAC for BRIMONIDINE 0.2% EYE DROP has ranged from a low of $0.4128 (Nov 20, 2024) to a high of $0.9515 (Jun 10, 2020), with a median of $0.6146 per ML.

Are there cheaper alternatives to BRIMONIDINE 0.2% EYE DROP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRIMONIDINE 0.2% EYE DROP, is $0.5086 per ML — about 13% below BRIMONIDINE 0.2% EYE DROP.

Who manufactures BRIMONIDINE 0.2% EYE DROP?

BRIMONIDINE 0.2% EYE DROP (NDC 70069023201) is labeled by Somerset Therapeutics, LLC, and CMS classifies it as a generic product.